Hair health 20 October 2026

Scalp itching after using minoxidil – is it a sign that the medication is working, or an allergic reaction?

Medications and topical treatments for hair loss can cause irritation – a dermatologist examines the condition of the patient's scalp.

The use of topical preparations for hair loss—such as solutions containing minoxidil—can lead to localized dermatological issues in some patients. Symptoms like itching, burning, or flaking of the skin should neither be ignored nor interpreted as evidence that the treatment is working. Many myths have emerged regarding the mechanism of action of this substance; one of the most common misconceptions is the belief that intensifying itchiness indicates that the medication is “starting to take effect” within the hair follicles. In clinical practice, this is a flawed and potentially dangerous assumption.

Attention
The following material is for educational purposes only. The information provided in this article is not a substitute for professional medical advice, diagnosis, or dermatological or trichological treatment.

As physicians at PT CLINIC, we frequently encounter patients who attempt to “endure” significant discomfort, fearing that stopping the application will hinder hair regrowth. In reality, the key to safely and effectively addressing excessive hair loss lies in a precise differential diagnosis—one that includes both an assessment of the skin’s condition and the identification of any irritating components within the product’s formulation.

What is the difference between skin irritation and an allergic reaction to minoxidil?

Localized discomfort following the application of a liquid formulation to the scalp may stem from entirely different biological mechanisms, even though the symptoms experienced by the patient are clinically similar. Distinguishing between irritation (a toxic or drying effect of a substance) and allergic contact dermatitis (an immune system response) is fundamental to determining the subsequent therapeutic approach.

Attention
Symptoms such as persistent itching, burning, redness, or scaling of the scalp following the application of minoxidil may indicate the development of contact dermatitis, irritation, or an allergic reaction. Any changes to the treatment regimen or discontinuation of the medication should always be discussed with a specialist. If systemic symptoms occur—such as difficulty breathing or swelling—immediate medical attention is required.

Scalp irritation typically manifests as a burning sensation, a feeling of tightness, and dryness of the epidermis at the site of application. It is often dose-dependent, occurring more frequently when a product is used in excess or applied to a compromised epidermal barrier. An allergic reaction (allergic contact dermatitis), by contrast, is characterized by intense, diffuse itching, marked redness, and inflammatory papules; in some cases, it may also present as weeping lesions or severe, dandruff-like scaling. Such a sensitivity may not appear immediately, but rather after weeks or even months of regular product use, as the immune system becomes gradually sensitized.

Doctor's tip
The appearance of skin flaking after using minoxidil is sometimes mistakenly interpreted as a natural stage of regeneration. In reality, it is most often a defensive response by the skin to dryness—caused by the chemical carriers present in the product—or an emerging inflammatory reaction.

Propylene glycol (PG) and contact sensitization – the primary source of the problem

Traditional liquid minoxidil formulations contain propylene glycol (PG). This substance acts as a key solvent, keeping the active ingredient in solution and facilitating its penetration through the stratum corneum of the epidermis into the hair follicles. Unfortunately, propylene glycol is also a common and potent allergen and irritant.

In patients with a sensitive scalp or coexisting dermatoses (such as seborrheic dermatitis), the presence of glycol in a preparation often triggers immediate irritation. If a contact allergy to this ingredient is suspected, specialized diagnostic procedures—such as patch testing conducted under the supervision of a dermatologist—become necessary. These tests allow for a definitive confirmation or exclusion of hypersensitivity to propylene glycol (PG) or other excipients contained in the medication.

What other side effects and phenomena accompany the treatment?

The use of medications that stimulate hair growth is associated with a range of transient bodily reactions. Local adverse effects are the most common; however, in rarer cases, systemic symptoms may occur, resulting from the absorption of the active substance into the bloodstream.

It is worth noting a phenomenon known as telogen effluvium—an increase in hair shedding typically observed within the first 2–6 weeks of starting treatment. This occurs because the hair growth cycle becomes synchronized, with a new generation of hair strands pushing out older, miniaturizing ones. While this process is a natural part of how the medication works, it should not be confused with itching or skin inflammation caused by an allergic reaction.

Rare but serious symptoms that require immediate medical consultation include:

  • Heart palpitations, tachycardia, and a sensation of an irregular heartbeat
  • Sudden onset of dizziness or episodes of fainting
  • Chest pain described as a feeling of pressure
  • Peripheral edema of the lower limbs, face, or eyelids
  • Generalized hypersensitivity reactions of an anaphylactic nature

Changing the drug formulation: does minoxidil foam solve the problem of itching?

If diagnostics reveal that an intolerance to propylene glycol is the source of the problem, the standard course of action is to change the form of the medication. Pharmaceutical products in the form of a foam are available on the market; in most cases, these do not contain propylene glycol, relying instead on other carriers such as fatty alcohols and water.

Such a modification of the formulation significantly improves patient comfort and allows for the continuation of effective therapy without the burden of itching and flaking. It should be noted, however, that the foam does not eliminate the risk of hypersensitivity to minoxidil itself or to other excipients. Therefore, any change in medication should be preceded by a thorough analysis of the product’s composition and a consultation with a specialist.

In cases where switching to a different topical preparation fails to provide relief and the scalp continues to exhibit signs of inflammation, at PT CLINIC we recommend discontinuing topical medications and directing the patient’s attention toward modern, non-irritating therapeutic alternatives that stimulate hair follicles without the use of substances that irritate the epidermis.

What can you do in the meantime? Safe scalp care before your doctor’s visit

Before you reach your follow-up appointment at the dermatologist’s office, your scalp may need immediate soothing and relief. In the event of intense burning or itching, it is worth following a few safe, short-term measures:

  • Gentle cleansing: Use only hypoallergenic, mild, pharmacy-grade shampoos designed for a sensitive scalp (free from harsh detergents like SLS/SLES and added fragrances).
  • Strictly no scratching: Scratching itchy areas leads to micro-injuries of the epidermis, which drastically increases the risk of a secondary bacterial infection and exacerbates inflammation.
  • Avoid alcohol-based products and styling: While your scalp is irritated, refrain from using hairsprays, dry shampoos, or any other styling products, as these can further dry out the skin.
  • Natural relief: You can opt for moisturizing emulsions from the pharmacy or products containing panthenol and allantoin, which support the restoration of a damaged epidermal barrier.

Diagnostics and a professional approach to scalp health

Experimenting on one’s own with various product concentrations, frequently switching cosmetic brands, or ignoring signals sent by the skin very often leads to a worsening of the clinical condition and an intensification of inflammatory processes—which, in turn, can accelerate the miniaturization of hair follicles. The key to effective treatment lies in a thorough assessment of the scalp’s condition through advanced diagnostic testing.

Doctor's tip
At PT CLINIC in Warsaw, diagnosis is based on a detailed medical interview, laboratory tests (including a thyroid panel, ferritin, iron levels, and androgen hormones), and a precise trichoscopic examination. This allows for the assessment of hair density, the condition of hair follicles, and the degree of vascularity of the scalp, which allows for the selection of a safe and targeted treatment path. Piotr Turkowski, MD, PhD .
Don’t let irritation and itching disrupt your journey toward healthy hair. Consult with the experienced team of specialists at PT CLINIC in Warsaw and gain the assurance of a safe treatment plan tailored to your body’s individual needs.

Frequently Asked Questions (FAQ)

No, that is one of the most common dermatological myths. Persistent itching, burning, or flaking of the skin is not proof that a medication is “starting to work” within the hair follicles. In reality, these are signs of chemical irritation or the development of contact dermatitis—conditions which, if ignored, can actually accelerate the process of hair miniaturization.

Epidermal peeling that resembles dandruff is most often the result of severe skin dryness caused by chemical carriers present in the product (primarily propylene glycol). The first step should be to consult a dermatologist, who will assess the condition of the epidermis, rule out fungal infections or seborrheic dermatitis, and consider switching the product to a glycol-free formulation (such as a foam).

If tests or observation indicate an intolerance to propylene glycol, the standard approach is to switch to a foam-based minoxidil formulation, which typically does not contain this ingredient. In the event that hypersensitivity persists, a physician may recommend discontinuing topical medications and adopting alternative methods for stimulating hair growth, such as the use of copper peptides or in-office clinical treatments.

No. Temporary telogen effluvium (increased hair shedding during the first few weeks of treatment) is solely related to a shift in the hair growth cycle, where a new generation of hair pushes out strands that are undergoing miniaturization. This process does not cause inflammation, redness, or itching of the scalp. If itching occurs concurrently, it stems from a different cause (typically contact-related).

Bibliography and medical sources

  1. Wytyczne Polskiego Towarzystwa Dermatologicznego (PTD) w zakresie diagnostyki i leczenia łysienia androgenowego oraz rozpoznawania kontaktowego zapalenia skóry.
  2. European Academy of Dermatology and Venereology (EADV) – stanowiska ekspertów dotyczące bezpieczeństwa stosowania leków miejscowych i tolerancji nośników chemicznych w trychologii.
i

The information presented on our blog is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a doctor or a trichologist at our clinic before taking any action.

Leave a Reply

Your email address will not be published. Required fields are marked *